HEADER TRANSFERASE 07-JUN-06 2H8H TITLE SRC KINASE IN COMPLEX WITH A QUINAZOLINE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: P60-SRC, C- SRC, PP60C-SRC; COMPND 5 EC: 2.7.10.2; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SRC, SRC1; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: SF9 CELLS; SOURCE 10 EXPRESSION_SYSTEM_VECTOR: BACULOVIRUS KEYWDS SRC KINASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR L.R.OTTERBEIN,R.NORMAN,R.A.PAUPTIT,S.ROWSELL,J.BREED REVDAT 5 03-APR-24 2H8H 1 REMARK LINK REVDAT 4 01-JUL-15 2H8H 1 HETSYN REVDAT 3 13-JUL-11 2H8H 1 VERSN REVDAT 2 24-FEB-09 2H8H 1 VERSN REVDAT 1 21-NOV-06 2H8H 0 JRNL AUTH L.F.HENNEQUIN,J.ALLEN,J.BREED,J.CURWEN,M.FENNELL,T.P.GREEN, JRNL AUTH 2 C.LAMBERT-VAN DER BREMPT,R.MORGENTIN,R.A.NORMAN,A.OLIVIER, JRNL AUTH 3 L.OTTERBEIN,P.A.PLE,N.WARIN,G.COSTELLO JRNL TITL N-(5-CHLORO-1,3-BENZODIOXOL-4-YL) JRNL TITL 2 -7-[2-(4-METHYLPIPERAZIN-1-YL)ETHOXY]-5- JRNL TITL 3 (TETRAHYDRO-2H-PYRAN-4-YLOXY)QUINAZOLIN-4-AMINE, A NOVEL, JRNL TITL 4 HIGHLY SELECTIVE, ORALLY AVAILABLE, DUAL-SPECIFIC C-SRC/ABL JRNL TITL 5 KINASE INHIBITOR. JRNL REF J.MED.CHEM. V. 49 6465 2006 JRNL REFN ISSN 0022-2623 JRNL PMID 17064066 JRNL DOI 10.1021/JM060434Q REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.67 REMARK 3 DATA CUTOFF (SIGMA(F)) : 1.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.5 REMARK 3 NUMBER OF REFLECTIONS : 29365 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.207 REMARK 3 R VALUE (WORKING SET) : 0.204 REMARK 3 FREE R VALUE : 0.272 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1566 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.26 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1971 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 87.93 REMARK 3 BIN R VALUE (WORKING SET) : 0.3060 REMARK 3 BIN FREE R VALUE SET COUNT : 105 REMARK 3 BIN FREE R VALUE : 0.3440 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3581 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 38 REMARK 3 SOLVENT ATOMS : 221 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 34.12 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.79000 REMARK 3 B22 (A**2) : 0.46000 REMARK 3 B33 (A**2) : -2.25000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.245 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.225 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.169 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 15.374 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.946 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.904 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3735 ; 0.013 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 3297 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5067 ; 1.444 ; 1.978 REMARK 3 BOND ANGLES OTHERS (DEGREES): 7685 ; 1.026 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 448 ; 6.897 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 174 ;37.339 ;23.678 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 638 ;17.139 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 27 ;21.777 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 538 ; 0.081 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4125 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 774 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 741 ; 0.203 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 3233 ; 0.186 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1814 ; 0.187 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 2068 ; 0.088 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 184 ; 0.166 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): 1 ; 0.035 ; 0.200 REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 13 ; 0.077 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 51 ; 0.256 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 18 ; 0.196 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2286 ; 0.840 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 904 ; 0.144 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3600 ; 1.394 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1694 ; 1.842 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1467 ; 2.910 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 85 A 529 REMARK 3 ORIGIN FOR THE GROUP (A): 19.4577 32.8529 66.7210 REMARK 3 T TENSOR REMARK 3 T11: -0.0900 T22: -0.0778 REMARK 3 T33: -0.0451 T12: 0.0460 REMARK 3 T13: 0.0038 T23: 0.0137 REMARK 3 L TENSOR REMARK 3 L11: 0.6254 L22: 0.9980 REMARK 3 L33: 0.7640 L12: 0.4351 REMARK 3 L13: -0.2318 L23: -0.0904 REMARK 3 S TENSOR REMARK 3 S11: -0.0081 S12: 0.0127 S13: -0.0033 REMARK 3 S21: -0.0360 S22: 0.0002 S23: -0.0060 REMARK 3 S31: -0.1010 S32: -0.0488 S33: 0.0079 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 2H8H COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-JUN-06. REMARK 100 THE DEPOSITION ID IS D_1000038061. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 27-NOV-03 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-4 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL MONOCHROMATOR REMARK 200 OPTICS : TOROIDAL FOCUSING MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : MOSFLM REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29365 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 49.800 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.5 REMARK 200 DATA REDUNDANCY : 3.400 REMARK 200 R MERGE (I) : 0.08300 REMARK 200 R SYM (I) : 0.11500 REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.32 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.2 REMARK 200 DATA REDUNDANCY IN SHELL : 3.30 REMARK 200 R MERGE FOR SHELL (I) : 0.58600 REMARK 200 R SYM FOR SHELL (I) : 0.78800 REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: IN HOUSE REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.42 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.58 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 50 MM PIPES PH 6.5, 10 MM DTT, 100 MM REMARK 280 SODIUM CHLORIDE AND 4 TO 9% PEG4000 (W/V), VAPOR DIFFUSION, REMARK 280 SITTING DROP, TEMPERATURE 288K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 24.90300 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 85.78300 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 36.23350 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 85.78300 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 24.90300 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 36.23350 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -1 REMARK 465 SER A 0 REMARK 465 ASN A 1 REMARK 465 LYS A 2 REMARK 465 SER A 3 REMARK 465 LYS A 4 REMARK 465 PRO A 5 REMARK 465 LYS A 6 REMARK 465 ASP A 7 REMARK 465 ALA A 8 REMARK 465 SER A 9 REMARK 465 GLN A 10 REMARK 465 ARG A 11 REMARK 465 ARG A 12 REMARK 465 ARG A 13 REMARK 465 SER A 14 REMARK 465 LEU A 15 REMARK 465 GLU A 16 REMARK 465 PRO A 17 REMARK 465 ALA A 18 REMARK 465 GLU A 19 REMARK 465 ASN A 20 REMARK 465 VAL A 21 REMARK 465 HIS A 22 REMARK 465 GLY A 23 REMARK 465 ALA A 24 REMARK 465 GLY A 25 REMARK 465 GLY A 26 REMARK 465 GLY A 27 REMARK 465 ALA A 28 REMARK 465 PHE A 29 REMARK 465 PRO A 30 REMARK 465 ALA A 31 REMARK 465 SER A 32 REMARK 465 GLN A 33 REMARK 465 THR A 34 REMARK 465 PRO A 35 REMARK 465 SER A 36 REMARK 465 LYS A 37 REMARK 465 PRO A 38 REMARK 465 ALA A 39 REMARK 465 SER A 40 REMARK 465 ALA A 41 REMARK 465 ASP A 42 REMARK 465 GLY A 43 REMARK 465 HIS A 44 REMARK 465 ARG A 45 REMARK 465 GLY A 46 REMARK 465 PRO A 47 REMARK 465 SER A 48 REMARK 465 ALA A 49 REMARK 465 ALA A 50 REMARK 465 PHE A 51 REMARK 465 ALA A 52 REMARK 465 PRO A 53 REMARK 465 ALA A 54 REMARK 465 ALA A 55 REMARK 465 ALA A 56 REMARK 465 GLU A 57 REMARK 465 PRO A 58 REMARK 465 LYS A 59 REMARK 465 LEU A 60 REMARK 465 PHE A 61 REMARK 465 GLY A 62 REMARK 465 GLY A 63 REMARK 465 PHE A 64 REMARK 465 ASN A 65 REMARK 465 SER A 66 REMARK 465 SER A 67 REMARK 465 ASP A 68 REMARK 465 THR A 69 REMARK 465 VAL A 70 REMARK 465 THR A 71 REMARK 465 SER A 72 REMARK 465 PRO A 73 REMARK 465 GLN A 74 REMARK 465 ARG A 75 REMARK 465 ALA A 76 REMARK 465 GLY A 77 REMARK 465 PRO A 78 REMARK 465 LEU A 79 REMARK 465 ALA A 80 REMARK 465 GLY A 81 REMARK 465 GLY A 82 REMARK 465 VAL A 83 REMARK 465 THR A 84 REMARK 465 GLY A 530 REMARK 465 GLU A 531 REMARK 465 ASN A 532 REMARK 465 LEU A 533 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU A 207 O REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 112 108.33 -161.73 REMARK 500 GLU A 115 -151.24 -163.08 REMARK 500 GLU A 115 -163.85 -178.49 REMARK 500 ASP A 208 -50.61 68.25 REMARK 500 ASP A 235 -114.87 41.97 REMARK 500 ASP A 258 18.74 57.54 REMARK 500 TRP A 260 -70.75 -149.51 REMARK 500 GLU A 339 132.60 -39.97 REMARK 500 ARG A 385 -8.86 75.83 REMARK 500 ASP A 386 51.42 -150.97 REMARK 500 GLU A 486 -3.06 75.30 REMARK 500 GLU A 524 152.43 -40.76 REMARK 500 PTR A 527 -140.08 -119.01 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ASP A 208 SER A 209 148.92 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE H8H A 534 DBREF 2H8H A -1 533 UNP P12931 SRC_HUMAN 1 535 SEQRES 1 A 535 GLY SER ASN LYS SER LYS PRO LYS ASP ALA SER GLN ARG SEQRES 2 A 535 ARG ARG SER LEU GLU PRO ALA GLU ASN VAL HIS GLY ALA SEQRES 3 A 535 GLY GLY GLY ALA PHE PRO ALA SER GLN THR PRO SER LYS SEQRES 4 A 535 PRO ALA SER ALA ASP GLY HIS ARG GLY PRO SER ALA ALA SEQRES 5 A 535 PHE ALA PRO ALA ALA ALA GLU PRO LYS LEU PHE GLY GLY SEQRES 6 A 535 PHE ASN SER SER ASP THR VAL THR SER PRO GLN ARG ALA SEQRES 7 A 535 GLY PRO LEU ALA GLY GLY VAL THR THR PHE VAL ALA LEU SEQRES 8 A 535 TYR ASP TYR GLU SER ARG THR GLU THR ASP LEU SER PHE SEQRES 9 A 535 LYS LYS GLY GLU ARG LEU GLN ILE VAL ASN ASN THR GLU SEQRES 10 A 535 GLY ASP TRP TRP LEU ALA HIS SER LEU SER THR GLY GLN SEQRES 11 A 535 THR GLY TYR ILE PRO SER ASN TYR VAL ALA PRO SER ASP SEQRES 12 A 535 SER ILE GLN ALA GLU GLU TRP TYR PHE GLY LYS ILE THR SEQRES 13 A 535 ARG ARG GLU SER GLU ARG LEU LEU LEU ASN ALA GLU ASN SEQRES 14 A 535 PRO ARG GLY THR PHE LEU VAL ARG GLU SER GLU THR THR SEQRES 15 A 535 LYS GLY ALA TYR CYS LEU SER VAL SER ASP PHE ASP ASN SEQRES 16 A 535 ALA LYS GLY LEU ASN VAL LYS HIS TYR LYS ILE ARG LYS SEQRES 17 A 535 LEU ASP SER GLY GLY PHE TYR ILE THR SER ARG THR GLN SEQRES 18 A 535 PHE ASN SER LEU GLN GLN LEU VAL ALA TYR TYR SER LYS SEQRES 19 A 535 HIS ALA ASP GLY LEU CYS HIS ARG LEU THR THR VAL CYS SEQRES 20 A 535 PRO THR SER LYS PRO GLN THR GLN GLY LEU ALA LYS ASP SEQRES 21 A 535 ALA TRP GLU ILE PRO ARG GLU SER LEU ARG LEU GLU VAL SEQRES 22 A 535 LYS LEU GLY GLN GLY CYS PHE GLY GLU VAL TRP MET GLY SEQRES 23 A 535 THR TRP ASN GLY THR THR ARG VAL ALA ILE LYS THR LEU SEQRES 24 A 535 LYS PRO GLY THR MET SER PRO GLU ALA PHE LEU GLN GLU SEQRES 25 A 535 ALA GLN VAL MET LYS LYS LEU ARG HIS GLU LYS LEU VAL SEQRES 26 A 535 GLN LEU TYR ALA VAL VAL SER GLU GLU PRO ILE TYR ILE SEQRES 27 A 535 VAL THR GLU TYR MET SER LYS GLY SER LEU LEU ASP PHE SEQRES 28 A 535 LEU LYS GLY GLU THR GLY LYS TYR LEU ARG LEU PRO GLN SEQRES 29 A 535 LEU VAL ASP MET ALA ALA GLN ILE ALA SER GLY MET ALA SEQRES 30 A 535 TYR VAL GLU ARG MET ASN TYR VAL HIS ARG ASP LEU ARG SEQRES 31 A 535 ALA ALA ASN ILE LEU VAL GLY GLU ASN LEU VAL CYS LYS SEQRES 32 A 535 VAL ALA ASP PHE GLY LEU ALA ARG LEU ILE GLU ASP ASN SEQRES 33 A 535 GLU TYR THR ALA ARG GLN GLY ALA LYS PHE PRO ILE LYS SEQRES 34 A 535 TRP THR ALA PRO GLU ALA ALA LEU TYR GLY ARG PHE THR SEQRES 35 A 535 ILE LYS SER ASP VAL TRP SER PHE GLY ILE LEU LEU THR SEQRES 36 A 535 GLU LEU THR THR LYS GLY ARG VAL PRO TYR PRO GLY MET SEQRES 37 A 535 VAL ASN ARG GLU VAL LEU ASP GLN VAL GLU ARG GLY TYR SEQRES 38 A 535 ARG MET PRO CYS PRO PRO GLU CYS PRO GLU SER LEU HIS SEQRES 39 A 535 ASP LEU MET CYS GLN CYS TRP ARG LYS GLU PRO GLU GLU SEQRES 40 A 535 ARG PRO THR PHE GLU TYR LEU GLN ALA PHE LEU GLU ASP SEQRES 41 A 535 TYR PHE THR SER THR GLU PRO GLN PTR GLN PRO GLY GLU SEQRES 42 A 535 ASN LEU MODRES 2H8H PTR A 527 TYR O-PHOSPHOTYROSINE HET PTR A 527 16 HET H8H A 534 38 HETNAM PTR O-PHOSPHOTYROSINE HETNAM H8H N-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-7-[2-(4- HETNAM 2 H8H METHYLPIPERAZIN-1-YL)ETHOXY]-5-(TETRAHYDRO-2H-PYRAN-4- HETNAM 3 H8H YLOXY)QUINAZOLIN-4-AMINE HETSYN PTR PHOSPHONOTYROSINE HETSYN H8H SARACATINIB FORMUL 1 PTR C9 H12 N O6 P FORMUL 2 H8H C27 H32 CL N5 O5 FORMUL 3 HOH *221(H2 O) HELIX 1 1 SER A 142 GLU A 146 5 5 HELIX 2 2 THR A 154 LEU A 163 1 10 HELIX 3 3 SER A 222 HIS A 233 1 12 HELIX 4 4 PRO A 263 GLU A 265 5 3 HELIX 5 5 SER A 303 LEU A 317 1 15 HELIX 6 6 LEU A 346 LYS A 351 1 6 HELIX 7 7 LYS A 351 LYS A 356 1 6 HELIX 8 8 ARG A 359 MET A 380 1 22 HELIX 9 9 ARG A 388 ALA A 390 5 3 HELIX 10 10 GLU A 396 LEU A 398 5 3 HELIX 11 11 ASP A 413 ALA A 418 1 6 HELIX 12 12 PRO A 425 THR A 429 5 5 HELIX 13 13 ALA A 430 GLY A 437 1 8 HELIX 14 14 THR A 440 THR A 456 1 17 HELIX 15 15 VAL A 467 ARG A 477 1 11 HELIX 16 16 PRO A 488 TRP A 499 1 12 HELIX 17 17 GLU A 502 ARG A 506 5 5 HELIX 18 18 THR A 508 ASP A 518 1 11 SHEET 1 A 5 THR A 129 PRO A 133 0 SHEET 2 A 5 TRP A 118 SER A 123 -1 N ALA A 121 O GLY A 130 SHEET 3 A 5 ARG A 107 ASN A 112 -1 N GLN A 109 O HIS A 122 SHEET 4 A 5 PHE A 86 ALA A 88 -1 N PHE A 86 O LEU A 108 SHEET 5 A 5 VAL A 137 PRO A 139 -1 O ALA A 138 N VAL A 87 SHEET 1 B 6 THR A 218 PHE A 220 0 SHEET 2 B 6 PHE A 212 THR A 215 -1 N PHE A 212 O PHE A 220 SHEET 3 B 6 GLY A 196 LYS A 206 -1 N ARG A 205 O TYR A 213 SHEET 4 B 6 TYR A 184 ASP A 192 -1 N VAL A 188 O LYS A 200 SHEET 5 B 6 THR A 171 GLU A 176 -1 N THR A 171 O SER A 189 SHEET 6 B 6 THR A 243 VAL A 244 1 O THR A 243 N PHE A 172 SHEET 1 C 5 LEU A 267 GLN A 275 0 SHEET 2 C 5 GLY A 279 TRP A 286 -1 O MET A 283 N VAL A 271 SHEET 3 C 5 THR A 290 LEU A 297 -1 O ILE A 294 N TRP A 282 SHEET 4 C 5 TYR A 335 THR A 338 -1 O THR A 338 N ALA A 293 SHEET 5 C 5 LEU A 325 VAL A 329 -1 N ALA A 327 O VAL A 337 SHEET 1 D 3 GLY A 344 SER A 345 0 SHEET 2 D 3 ILE A 392 VAL A 394 -1 O VAL A 394 N GLY A 344 SHEET 3 D 3 CYS A 400 VAL A 402 -1 O LYS A 401 N LEU A 393 LINK C GLN A 526 N PTR A 527 1555 1555 1.33 LINK C PTR A 527 N GLN A 528 1555 1555 1.33 CISPEP 1 GLU A 332 PRO A 333 0 -2.45 SITE 1 AC1 13 LEU A 273 VAL A 281 ALA A 293 LYS A 295 SITE 2 AC1 13 THR A 338 GLU A 339 TYR A 340 MET A 341 SITE 3 AC1 13 SER A 342 GLY A 344 LEU A 393 ASP A 404 SITE 4 AC1 13 HOH A 543 CRYST1 49.806 72.467 171.566 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020078 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013799 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005829 0.00000